HOTH
NASDAQ · Pharmaceuticals
Hoth Therapeutics Inc
$0.79
-0.01 (-0.84%)
Open$0.80
Previous Close$0.80
Day High$0.82
Day Low$0.78
52W High$2.45
52W Low$0.49
Volume—
Avg Volume732.0K
Market Cap30.69M
P/E Ratio—
EPS$-0.81
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |
| Rev Growth | +13.3% | +17.8% | +20.0% |
| Debt/Equity | 0.67 | 0.60 | 0.55 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |